A dual-type I/II photosensitizer targeting the plasma membrane for photodynamic therapy
Miaomiao Liu1, Huawei Huang1, Wei Quan2
1Institute of Optical Materials and Chemical Biology, Guangxi Key Laboratory of Electrochemical Energy Materials, School of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi 530004, PR China.
Abstract:
Photodynamic therapy is a highly efficient approach for inducing tumor cell death through the generation of reactive oxygen species mediated by photosensitizers. However, conventional photosensitizers are largely confined to the oxygen-dependent Type II pathway and lack the capability to target specific subcellular structures. To address these limitations, this study presented the rational design of a cell membrane-targeted photosensitizer DAD, featuring a donor-π-acceptor architecture. In DAD, electron-donating group triphenylamine was conjugated via a carbon‑carbon double bond to pyridine-derived electron-accepting unit. Further incorporation of hydrophobic alkyl chain conferred amphiphilicity to DAD, enabling effective membrane anchoring on cells. Thanks to its aggregation-induced emission characteristics, DAD exhibited excellent photophysical properties. Upon visible light irradiation, DAD was capable of not only generating singlet oxygen via the Type II pathway, but also producing superoxide anions and hydroxyl radicals through the Type I mechanism, thereby offering the potential to overcome the limitations of photodynamic therapy efficacy associated with tumor hypoxia. More importantly, DAD specifically targeted the cell membrane and induced structural disruption of the membrane upon light exposure, leading to efficient tumor cell death. Therefore, this work provided valuable insights into the rational design of dual Type I/II photosensitizers and contributes to the development of cell membrane-targeted aggregation-induced emission photosensitizers for future cancer therapeutics.
Insights
Researchers developed a novel photosensitizer, DAD, that targets cancer cell membranes. This dual-action agent overcomes tumor hypoxia and enhances photodynamic therapy efficacy for improved cancer treatment.
Area of Science:
- Biochemistry
- Materials Science
- Oncology
Background:
- Photodynamic therapy (PDT) uses photosensitizers to generate reactive oxygen species (ROS) for tumor cell death.
- Conventional photosensitizers often rely on oxygen (Type II pathway) and lack specific subcellular targeting.
- Tumor hypoxia limits the efficacy of oxygen-dependent PDT.
Purpose of the Study:
- To design and synthesize a novel cell membrane-targeted photosensitizer with dual Type I/II ROS generation.
- To investigate the photophysical properties and therapeutic potential of the designed photosensitizer.
- To overcome limitations of conventional PDT, including tumor hypoxia and lack of specific targeting.
Main Methods:
- Rational design of a donor-π-acceptor photosensitizer (DAD) with amphiphilic properties for cell membrane anchoring.
- Synthesis and characterization of DAD, incorporating triphenylamine and pyridine units.
- Evaluation of DAD's photophysical properties, ROS generation mechanisms (Type I and Type II), and aggregation-induced emission (AIE) characteristics.
- Assessment of DAD's cell membrane targeting, disruption, and tumor cell killing efficacy upon visible light irradiation.
Main Results:
- DAD exhibited excellent photophysical properties due to its AIE characteristics.
- DAD effectively generated both singlet oxygen (Type II) and superoxide/hydroxyl radicals (Type I) upon irradiation.
- DAD demonstrated specific targeting and disruption of cancer cell membranes.
- Light-activated DAD induced efficient cancer cell death, showing potential to overcome tumor hypoxia.
Conclusions:
- The study successfully designed a dual Type I/II photosensitizer (DAD) with cell membrane-targeting capabilities.
- DAD's amphiphilicity and AIE properties contribute to its enhanced photodynamic efficacy.
- This work provides a foundation for developing advanced photosensitizers for cancer therapeutics, addressing PDT limitations.
Related Concept Videos
01:22Photosystem II
The pigment molecules are arranged across two photosystem domains — the antenna complex and the reaction center. The main aim of the pigment...
01:27Photosystem I
Both these photosystems work in concert. An excited electron from PSII is relayed to PSI via an electron transport chain in the thylakoid membrane of the chloroplast, which is comprised of the carrier molecule plastoquinone, the dual-protein cytochrome complex, and plastocyanin. As electrons move between PSII and PSI, they lose energy and must be re-energized...